
EP 31 - Tretinoin, Adapalene and Retinol. Why FDA Approval Isn't Always Better.
Episode 31
How do we know which skincare ingredients actually work? Do cosmetics even work? Or are over the counter topical drugs the only way to reliably treat problem skin? In this discussion episode, hosts Natalie and Sadie reveal why some treatments are prescription-only while others are OTC, and why this matters more than you think. This week we are continuing our retinol conversation, and also revisiting some of our other recent topics like PDRN and Reale Actives, and explaining why cosmetic brands have no incentive to do good scientific studies. Discover how the FDA's outdated definitions make it tricky for brands to bring effective ingredients to market, and learn why some companies boldly blur the lines with ambitious claims. Uncover the real science behind retinoids, PDRN, and other active ingredients, debunking myths about strength, formulation, and regulation. We are breaking down why tretinoin is prescription-only, but other retinoids aren't. The complex dance between FDA definitions, bioavailability, and product efficacy, and why some ingredients get labeled as drugs while others stay in the cosmetic market, despite similar effects. We’re chatting about practical tips for choosing safer, more effective skincare, whether you’re a novice or seasoned professional. In a world flooded with confusing claims and fluctuating regulations, knowing the difference could save you time, money, and skin misery.
Publisher
Beauty by the Beaker
Link
podcasters.spotify.com/pod/show/beauty-by-the-beaker/episodes/EP-31---Tretinoin--Adapalene-and-Retinol--Why-FDA-Approval-Isnt-Always-Better-e3i94b2
Published
April 22, 2026
Duration
42 min
Format
Podcast
Category
Issues · Science
Source
RSS feed
Beauty by the Beaker
@beautybythebeaker
#tretinoin #adapalene #fdaapprovalisnt #chemistry
